RS 09

Discontinued Product

5928 has been discontinued.

View all Toll-like Receptors products.
说明: TLR4 peptide agonist; acts as an adjuvant in vivo
说明书
引用文献
评论
通路 (1)

生物活性 for RS 09

RS 09 is a TLR4 agonist. Promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro. Acts as an adjuvant in vivo; enhances X-15 specific antibody serum concentrations, when administered with X-15-KLH in mice.

技术数据 for RS 09

分子量 691.78
公式 C31H49N9O9
序列 APPHALS
储存 Store at -20°C
CAS Number 1449566-36-2
PubChem ID 121513902
InChI Key SHYNPSTXGFDOBD-HRALPVODSA-N
Smiles [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for RS 09

分析证书/产品说明书
选择另一批次:

参考文献 for RS 09

参考文献是支持产品生物活性的出版物。

Li et al (2016) Intranasal vaccination against HIV-1 with adenoviral vector-based nanocomplex using synthetic TLR-4 agonist peptide as adjuvant. Mol.Pharm. 13 885 PMID: 26824411

Shanmugam et al (2012) Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS One 7 e30839 PMID: 22363498

按产品操作查看相关产品

查看全部 Toll-like Receptor Agonists

关键词: RS 09, RS 09 supplier, RS09, TLR4, peptides, agonists, toll-like, receptors, agonism, adjuvants, Toll-like, Receptors, 5928, Tocris Bioscience

篇 RS 09 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 RS 09 的引用文献。

RS 09 的评论

目前没有该产品的评论。 Be the first to review RS 09 and earn rewards!

Have you used RS 09?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Pathways for RS 09

Toll-like Receptor Signaling Pathway

Toll-like Receptor Signaling Pathway

TLR signaling is involved in the cellular response to threatening molecules such as bacteria and viruses. It results in an inflammatory and immmunological response.